Skip to main content
Premium Trial:

Request an Annual Quote

Bioinformatics Pioneer Chris Sander Accepts Position with Millennium

Premium

CAMBRIDGE, Mass.--Chris Sander, a researcher with the European Molecular Biology Laboratory (EMBL) who is internationally recognized as a pioneer in the field of bioinformatics, has agreed to serve as chief information officer of Millennium Information, a new spinoff from Millennium Pharmaceuticals here. In the new position Sander will lead the company "in conceptualizing and prototyping information products and services."

Among Sander's achievements in bioinformatics is the invention of GeneQuiz, a widely used suite of computational products for functional genomics, and other work in the development of software technology to analyze and predict the properties of proteins in living cells. He also played a key role in establishing EMBL's Department of Biocomputing.

"Chris's leadership in computational biology, genome analysis, and software development will enable Millennium Information to rapidly develop information products and services that effectively leverage Millennium's integrated technology platform into yet another important new business," commented Nick Galakatos, Millennium's vice-president for new businesses.

Filed under

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.